Propafenone Hydrochloride Capsule, Extended Release
NDC Package 0832-0740-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Propafenone Hydrochloride capsules is propafenone hydrochloride extended-release capsules are indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease. This formulation utilizes a capsule, extended release delivery system. Marketed by Upsher-smith Laboratories, Llc, this product is identified by NDC 0832-0740 and is authorized under FDA application ANDA212744.

Identification & Billing

NDC Package Code
0832-0740-60
Package Description
60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Product Code
0832-0740
11-Digit Billing Format
00832074060
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
60 EA
RxNorm Crosswalk
  • RxCUI: 861156 - propafenone HCl 225 MG 12HR Extended Release Oral Capsule
  • RxCUI: 861156 - 12 HR propafenone hydrochloride 225 MG Extended Release Oral Capsule
  • RxCUI: 861156 - propafenone hydrochloride 225 MG 12 HR Extended Release Oral Capsule
  • RxCUI: 861164 - propafenone HCl 325 MG 12HR Extended Release Oral Capsule
  • RxCUI: 861164 - 12 HR propafenone hydrochloride 325 MG Extended Release Oral Capsule

Clinical Specifications

Proprietary Name
Propafenone Hydrochloride
Non-Proprietary Name
Propafenone Hydrochloride
Substance Name
Propafenone Hydrochloride
Dosage Form
Capsule, Extended Release - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PROPAFENONE HYDROCHLORIDE 225 mg/1
Pharmacologic Class
Antiarrhythmic - [EPC] (Established Pharmacologic Class)
Usage Information
Propafenone hydrochloride extended-release capsules are indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease.

Regulatory & Marketing

Labeler Name
Upsher-smith Laboratories, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA212744
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-25-2020
End Marketing Date
11-30-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0832-0740-60 identifies a specific commercial package of 60 capsule, extended release in 1 bottle of Propafenone Hydrochloride, a human prescription drug labeled by Upsher-smith Laboratories, Llc. This capsule, extended release is formulated for oral use and contains propafenone hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Upsher-smith Laboratories, Llc on June 25, 2020.

How is this Upsher-smith Laboratories, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00832074060. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0832-0740-60
11-Digit CMS (5-4-2)
00832-0740-60

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.